Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8780862 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
The use of HC during postmolar follow-up or GTN treatment does not seem to increase the risk of GTN or its severity and does not postpone the normalization of hCG levels.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
PatrÃcia Rangel Sobral Dantas, Izildinha Maestá, Jorge Rezende Filho, Joffre Amin Junior, Kevin M. Elias, Neil Howoritz, Antonio Braga, Ross S. Berkowitz,